Skip to search formSkip to main contentSkip to account menu

Leuvectin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Leuvectin (Vical Inc., San Diego, CA) is a gene transfer product in which a plasmid encoding the human interleukin‐2 (IL‐2) gene… 
Highly Cited
2001
Highly Cited
2001
Twenty-four patients with locally advanced prostate cancer (CaP) were enrolled in a phase I clinical trial using gene-based… 
Review
2001
Review
2001
  • A. Kaushik
  • Current opinion in investigational drugs
  • 2001
  • Corpus ID: 30058465
Vical's Leuvectin, a plasmid DNA expression vector encoding interleukin-2 (IL-2) complexed with a lipid delivery vehicle (DMRIE… 
2000
2000
Abstract Metastatic renal-cell carcinoma (RCC) is not responsive to conventional cytotoxic chemotherapy, but a subset of patients… 
Highly Cited
1999
Highly Cited
1999
PURPOSE We have completed a phase I study, followed by three phase I/II studies, in patients with metastatic melanoma, renal cell… 
Review
1999
Review
1999
Leuvectin is a plasmid DNA/lipid complex comprised of a plasmid DNA expression vector (VCL-1102, 30) encoding human interleukin…